CEACAM3 and colorectal carcinoma: The immunoscintigraphy analysis, with an anti-CEA monoclonal antibody fragment labeled with 99mTc, in patients with colorectal carcinoma recurrence, was evaluated as an effective method for early detection of pelvic and extrahepatic abdominal metastases [8].